A randomized controlled trial involving 2,400 patients across 15 medical centers has demonstrated that strict adherence to a Mediterranean diet can reverse early-stage non-alcoholic fatty liver disease within 12 months.
Trial Results
The study, published in The Lancet Gastroenterology, showed that 67% of participants following the Mediterranean diet protocol experienced significant reduction in liver fat content, compared to just 18% in the control group.
- Average liver fat reduction of 42% in the diet group versus 8% in controls
- Inflammatory markers decreased by 55% in participants with high adherence
- No pharmaceutical intervention was required for stage 1 patients
Clinical Implications
Hepatologists are now recommending dietary intervention as the first-line treatment for early-stage NAFLD, potentially reducing the need for expensive pharmacological treatments. The findings could affect treatment protocols for an estimated 80 million Americans living with fatty liver disease.
